HomeORGANIZATION
ORGANIZATION

US Exclusion from Foreign Price Adjustment Should Be Carefully Considered: PhRMA Japan Chief
(Feb.2.2017)

Patrik Jonsson, Chairman of PhRMA Japan-based Executive Committee
Patrik Jonsson, chairman of the Pharmaceutical Research and Manufacturers of America’s (PhRMA) Japan-based Executive Committee, on February 1 called for careful discussions on the proposed removal of US prices from the current “foreign price adjustment rule” for new drugs ...
(LOG IN FOR FULL STORY)

News Calendar